Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome‐specific probes

Wiley - Tập 50 Số 3 - Trang 153-159 - 2002
José María Sayagués1, María Dolores Tabernero2,1, A. Maíllo3,1, P. Díaz3,1, Ana Rasillo1, Bortoluci Aglae1, J.A. Gómez-Moreta3,1, Ángel Santos‐Briz4, Francisco Morales3, Alberto Órfão1
1Servicio General de Citometría, Departmento de Medicina y Centro de Investigaciones del Cáncer, Universidad de Salamanca, Salamanca, Spain
2Hospital Universitario de Salamanca, Unidad de Investigación, Salamanca, Spain
3Neurosurgery Service, Hospital Universitario de Salamanca, Salamanca, Spain
4Departament of Pathology, Hospital Universitario de Salamanca, Salamanca, Spain

Tóm tắt

Abstract

Objective: Although information on the cytogenetic characteristics of meningioma tumors has accumulated progressively over the past few decades, information on the genetic heterogeneity of meningiomas is still scanty. The aim of the present study was to analyze by interphase fluorescence in situ hybridization (FISH) the incidence of numerical abnormalities for chromosomes 1, 9, 10, 11, 14, 15, 17, 22, X, and Y in a group of 70 consecutive meningioma tumors. Another goal was to establish the potential associations among the altered chromosomes, as a way to assess both intertumoral and intratumoral heterogeneity. Methods: For the purpose of the study, 70 patients diagnosed with meningioma were analyzed. Interphase FISH for the detection of numerical abnormalities for chromosomes 1, 9, 10, 11, 14, 15, 17, 22, X, and Y was applied to fresh tumor samples from each of the patients studied. Results: The overall incidence of numerical abnormalities was 76%. Chromosome Y in males and chromosome 22 in the whole series were the most common abnormalities (46% and 61%, respectively). Despite the finding that monosomy of chromosome 22/22q deletions are the most frequent individual abnormality (53%), we have observed that chromosome gains are significantly more common than chromosome losses (60% versus 40%). Chromosome gains corresponded to abnormalities of chromosomes 1 (27%), 9 (25%), 10 (23%), 11 (22%), 14 (33%), 15 (22%), 17 (23%), and X in females (35%) and males (23%) whereas chromosome losses apart from chromosome 22 frequently involved chromosomes 14 (19%), X in males (23%), and Y in males (32%). Although an association was found among most gained chromosomes on one side and chromosome losses on the other side, different association patterns were observed. Furthermore, in the latter group, monosomy 22/22q was associated with monosomy X in females and monosomy 14/14q was associated with nulisomy Y in males. In addition, chromosome losses usually involved a large proportion of the tumor cells whereas chromosome gains were restricted to small tumor cell clones, including tetraploid cells. Conclusions: Our results show that meningiomas are genetically heterogeneous tumors that display different patterns of numerical chromosome changes, as assessed by interphase FISH. Cytometry (Clin. Cytometry) 50:153–159, 2002. © 2002 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1111/j.1750-3639.1990.tb00634.x

Dumanski JP, 1990, Molecular genetic analysis of chromosome 22 in 81 cases of meningioma, Cancer Res, 50, 5863

10.1016/0165-4608(86)90138-X

10.1097/00006123-199404000-00021

Lopez‐Gines C, 1989, Meningiomas: karyotypes and histological patterns, Clin Neuropathol, 8, 130

Poulsgard L, 1989, Cytogenetic studies of 19 meningiomas and their clinical significance. I, Anticancer Res, 9, 109

10.1016/0165-4608(95)00154-9

Scholz M, 1996, Intratumorous heterogeneity of chromosome 10 and 17 in meningiomas using non‐radioactive in situ hybridization, J Neurosurg Sci, 40, 17

10.1227/00006123-199306000-00002

10.1007/BF00275149

10.1016/0165-4608(82)90063-2

10.1038/216084a0

10.1002/gcc.2870030204

10.3171/jns.1992.76.6.0997

10.1002/(SICI)1097-0142(19980715)83:2<360::AID-CNCR21>3.0.CO;2-Q

Kasai H, 1995, Cytogenical analysis of brain tumors by FISH (fluorescence in situ hybridization) and FCM (flow cytometry), Noshuyo Byori, 12, 75

Zattara‐Cannoni H, 1998, Contribution of cytogenetics and FISH in the diagnosis of meningiomas. A study of 189 tumors, Ann Genet, 41, 164

Muller P, 1999, Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas, Clin Cancer Res, 5, 3569

10.1038/ng0294-180

10.1016/0165-4608(93)90239-I

10.1016/0165-4608(93)90140-H

10.1093/jnen/59.6.504

10.1002/(SICI)1097-0142(20000115)88:2<440::AID-CNCR27>3.0.CO;2-5

10.1002/(SICI)1098-2264(199608)16:4<265::AID-GCC7>3.0.CO;2-W

Simon M, 1995, Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression, Cancer Res, 55, 4696

10.1038/sj.onc.1202531

10.1038/sj.onc.1200853

Rempel SA, 1993, Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression, Cancer Res, 53, 2386

10.1073/pnas.84.24.9275

10.1097/00005072-199503000-00009

10.1073/pnas.84.15.5419

10.1159/000132863

Rubinstein L, 1972, Tumors on the central nervous system: atlas of tumor pathology

Russel DS, 1977, Pathology of tumors of the nervous system

Zulch KJ, 1979, Histologic typing of tumors of the central nervous system. International histological classification of tumors

10.1111/j.1750-3639.1993.tb00752.x

10.1016/S0344-0338(11)80747-8

10.1002/(SICI)1097-0320(19990615)38:3<118::AID-CYTO5>3.0.CO;2-J

Tabernero D, 1996, Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome‐specific probes, Am J Pathol, 149, 153

10.1016/0165-4608(94)90180-5

10.1016/0165-4608(87)90140-3

10.1016/0165-4608(88)90285-3

10.1016/0165-4608(89)90125-8

10.1073/pnas.84.14.5034

10.1126/science.2539641

10.1126/science.3919442

Rasio D, 1997, Characterization of the human homologue of RAD54: a gene located on chromosome 1p32 at a region of high loss of heterozygosity in breast tumors, Cancer Res, 57, 2378

10.1016/S0092-8674(00)80540-1

10.1038/38298